| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.28 | 6e-08 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.22 | 6e-08 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.26 | 7e-08 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.32 | 9e-08 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-07 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.28 | 2e-07 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.26 | 4e-07 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.25 | 4e-07 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.27 | 4e-07 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-07 |